10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker that is increasingly used for evaluation of systemic inflammation. This study was performed to investigate whether suPAR may possess a diagnostic value in patients with ventilator-associated pneumonia (VAP).

          Related collections

          Author and article information

          Journal
          Clin Respir J
          The clinical respiratory journal
          Wiley
          1752-699X
          1752-6981
          Nov 2017
          : 11
          : 6
          Affiliations
          [1 ] Department of Chest Diseases, Yuzuncu Yil University Medical Faculty, Van, Turkey.
          [2 ] Department of Infectious Diseases, Yuzuncu Yil University Medical Faculty, Van, Turkey.
          [3 ] Department of Infectious Disease, Ercis State Hospital, Van, Turkey.
          [4 ] Department of Anesthesiology and Intensive Care, Yuzuncu Yil University, Medical Faculty, Van, Turkey.
          Article
          10.1111/crj.12438
          26683264
          f8bce6bb-281d-48c5-bc00-4d9435665fd2
          History

          leukocyte count - ventilator-associated pneumonia,soluble urine plasminogen kinase activator,C reactive protein

          Comments

          Comment on this article